You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

Effects of Resveratrol on Endothelial Progenitor Cells and Their Contributions to Reendothelialization in Intima-injured Rats

J, Gu*; CQ, Wang*; HH, Fan; HY, Ding*; XL, Xie*; YM, Xu*; BY, Wang*; DJ, Huang*

Journal of Cardiovascular Pharmacology:
doi: 10.1097/01.fjc.0000211764.52012.e3
Original Articles

The aim of this study was to investigate the effects of resveratrol on endothelial progenitor cell (EPC) activities in vitro and on the mobilization of circulating EPCs, and reendothelialization in balloon-injured aorta of rats. After being isolated, cultured, and characterized, human EPCs were stimulated with resveratrol. We found that a low concentration of resveratrol (1 μM) led to significant enhanced activities of proliferation, migration, and adhesion, as well as promoting endothelial nitric acid synthetase (eNOS) expression in EPCs, whereas a high concentration (60 μM) inhibited the aforementioned functions and eNOS expression. In a rat model of injured aorta, a low dosage of resveratrol (10 mg/kg) increased the amount of EPCs in rat circulation as compared with placebo, whereas the result of a high dosage (50 mg/kg) did not reach statistical difference. In addition, 10 mg/kg of resveratrol both accelerated reendothelialization and inhibited neointimal formation; however, 50 mg/kg only reduced neointimal formation, which was not as effective as the previous one. eNOS expression in injured arteries was potently enhanced in the 10 mg/kg group, but not in the 50 mg/kg group.These findings suggest that a low dosage of resveratrol could markedly raise the proliferative, migrative, and adhesive activities of EPCs and upgrade eNOS expression in vitro as well as increase EPC mobilization, enhance eNOS expression, and accelerate the repair of injured artery; however, a high dosage cannot.

Author Information

*Department of Cardiology, Renji Hospital, affiliated to Shanghai Jiao-Tong University School of Medicine

Laboratory of Blood Engineering, Shanghai Blood Center, Shanghai, China

Supported by a grant from the National Natural Science Foundation of China (No. 30170365).

Reprints: ChangQian Wang, Department of Cardiology, Renji Hospital affiliated to Jiao-Tong University School of Medicine, Shanghai, 200001, China (e-mail:

Received for publication December 10, 2005; accepted February 13, 2006

© 2006 Lippincott Williams & Wilkins, Inc.